跳至主要内容
临床试验/NCT01229540
NCT01229540终止不适用

Clinical Research on Retinal Neovascularization of Diabetic Retinopathy

Tianjin Medical University1 个研究点 分布在 1 个国家开始时间: 2010年10月27日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
试验地点
1

研究概览

简要总结

Retinal neovascularization of diabetic retinopathy might be associated with genetic risk factors and environmental risk factors.

研究设计

研究类型
Interventional

入排标准

年龄范围
45 Years 至 74 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • T2DM was diagnosed according to the World Health Organization Expert Consultation Report 1999 and consisted of one of the following: fasting blood glucose (FBG) ≥7.0 mmol/L (≥126 mg/dL), blood glucose ≥11.1 mmol/L (≥200 mg/dL) 2 hours after an oral glucose tolerance test (OGTT); or a random blood glucose ≥11.1 mmol/L (≥200 mg/dL).
  • DR was clinically graded in accordance with the International Clinical Diabetic Retinopathy guidelines based on fundus fluorescence angiography.
  • All participants with PDR underwent a comprehensive dilated fundus examination to detect DR by indirect ophthalmoscopy and were diagnosed by fundus fluorescence angiography.

排除标准

  • Patients were excluded if they had acute complications of diabetes mellitus, type 1 diabetes mellitus, other types of diabetes, serious cardiovascular, hepatic, nephritic or other complications, other serious primary diseases or mental illness.

研究者

发起方
Tianjin Medical University
申办方类型
Other

研究点 (1)

Loading locations...

相似试验